Cambridge Investment Research Advisors
CDC icon

Cambridge Investment Research Advisors’s VictoryShares US EQ Income Enhanced Volatility Wtd ETF CDC Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CDC Stock Details CDC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.7M Buy
177,935
+3,057
+2% +$216K 0.03% 529
2025
Q4 		$11.5M Sell
174,878
-1,618
-0.9% -$107K 0.03% 529
2025
Q3 		$11.8M Buy
176,496
+5,996
+4% +$393K 0.03% 509
2025
Q2 		$10.9M Sell
170,500
-40,527
-19% -$2.53M 0.03% 509
2025
Q1 		$13.9M Sell
211,027
-7,338
-3% -$472K 0.05% 396
2024
Q4 		$13.7M Buy
218,365
+31,783
+17% +$2.06M 0.05% 390
2024
Q3 		$12.1M Buy
186,582
+6,697
+4% +$415K 0.04% 435
2024
Q2 		$10.5M Buy
179,885
+3,138
+2% +$184K 0.04% 441
2024
Q1 		$10.5M Buy
176,747
+4,949
+3% +$280K 0.04% 447
2023
Q4 		$9.72M Sell
171,798
-7,532
-4% -$421K 0.04% 424
2023
Q3 		$10M Sell
179,330
-21,410
-11% -$1.22M 0.05% 379
2023
Q2 		$11.6M Sell
200,740
-126,294
-39% -$7.43M 0.05% 340
2023
Q1 		$19.8M Sell
327,034
-122,942
-27% -$7.69M 0.1% 220
2022
Q4 		$27.9M Sell
449,976
-4,980
-1% -$311K 0.14% 145
2022
Q3 		$27M Buy
454,956
+301,665
+197% +$20M 0.15% 132
2022
Q2 		$10.1M Sell
153,291
-16,205
-10% -$1.13M 0.05% 331
2022
Q1 		$12.2M Buy
169,496
+106,875
+171% +$7.49M 0.06% 324
2021
Q4 		$4.36M Buy
62,621
+4,163
+7% +$280K 0.02% 703
2021
Q3 		$3.76M Sell
58,458
-21,782
-27% -$1.43M 0.02% 739
2021
Q2 		$5.18M Buy
80,240
+13,449
+20% +$875K 0.02% 602
2021
Q1 		$4.16M Buy
66,791
+20,126
+43% +$1.16M 0.02% 640
2020
Q4 		$2.51M Buy
46,665
+1,491
+3% +$76.3K 0.01% 807
2020
Q3 		$2.14M Buy
45,174
+2,866
+7% +$137K 0.01% 769
2020
Q2 		$1.97M Sell
42,308
-13,490
-24% -$615K 0.01% 782
2020
Q1 		$2.31M Sell
55,798
-27,934
-33% -$1.28M 0.02% 613
2019
Q4 		$4.11M Sell
83,732
-11,421
-12% -$541K 0.03% 535
2019
Q3 		$4.43M Buy
95,153
+52,248
+122% +$2.38M 0.04% 463
2019
Q2 		$1.95M Sell
42,905
-1,439
-3% -$64.7K 0.02% 723
2019
Q1 		$1.98M Sell
44,344
-636
-1% -$27.8K 0.02% 721
2018
Q4 		$1.9M Buy
44,980
+4,024
+10% +$183K 0.02% 648
2018
Q3 		$1.94M Buy
40,956
+2,645
+7% +$126K 0.02% 699
2018
Q2 		$1.77M Buy
38,311
+2,828
+8% +$129K 0.02% 691
2018
Q1 		$1.61M Sell
35,483
-10,804
-23% -$500K 0.02% 706
2017
Q4 		$2.15M Buy
46,287
+13,794
+42% +$629K 0.03% 560
2017
Q3 		$1.44M Buy
32,493
+847
+3% +$37K 0.02% 659
2017
Q2 		$1.37M Sell
31,646
-6,215
-16% -$268K 0.02% 659
2017
Q1 		$1.63M Sell
37,861
-143,029
-79% -$6.04M 0.03% 518
2016
Q4 		$7.47M Buy
180,890
+51,417
+40% +$2.06M 0.14% 137
2016
Q3 		$5.13M Buy
129,473
+119,546
+1,204% +$4.72M 0.1% 198
2016
Q2 		$382K Buy
9,927
+1,335
+16% +$50.3K 0.01% 1072
2016
Q1 		$325K Buy
+8,592
New +$304K 0.01% 1125

Other funds holding CDC

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.37B AUM 20.67% 1-Year Est. Return
AFW
Atlantic Family Wealth Coral Gables, Florida $138M AUM 14.54% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Cambridge Investment Research Advisors's CDC Position: Q1 2026 in Review

Cambridge Investment Research Advisors increased its VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) stake by 1.7% in Q1 2026, buying an estimated $216K and bringing the position to 177,935 shares worth $12.7M. The position accounts for 0.03% of the portfolio, ranked #529.

Cambridge Investment Research Advisors first reported a position in CDC in Q1 2016 and has held it in 41 quarters since. The position peaked at $27.9M in Q4 2022. 100 funds tracked by Wall St. Rank hold CDC as of Q1 2026.

  • Cambridge Investment Research Advisors held 177,935 shares of VictoryShares US EQ Income Enhanced Volatility Wtd ETF worth $12.7M as of Q1 2026.
  • Cambridge Investment Research Advisors bought 3,057 VictoryShares US EQ Income Enhanced Volatility Wtd ETF shares in Q1 2026, an estimated $216K.
  • VictoryShares US EQ Income Enhanced Volatility Wtd ETF made up 0.03% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #529 holding.
  • Cambridge Investment Research Advisors first reported a position in VictoryShares US EQ Income Enhanced Volatility Wtd ETF in Q1 2016 and has held it in 41 quarters since.
  • Cambridge Investment Research Advisors's VictoryShares US EQ Income Enhanced Volatility Wtd ETF position peaked at $27.9M in Q4 2022.
  • 100 funds tracked by Wall St. Rank held VictoryShares US EQ Income Enhanced Volatility Wtd ETF as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.